We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+28.57%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
AUM
$1.01B
AUM Growth
-$202M
Cap. Flow
-$355M
Cap. Flow %
-35.04%
Top 10 Hldgs %
17.77%
Holding
972
New
385
Increased
62
Reduced
71
Closed
428

Sector Composition

Rank Sector Weight
1 Healthcare 32.37%
2 Technology 10.24%
3 Industrials 10.18%
4 Financials 8.13%
5 Consumer Discretionary 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHRW icon
51
C.H. Robinson
CHRW
$22B
$4.46M 0.44%
+47,500
New +$4.53M
BURU
52
DELISTED
NUBURU INC
BURU
$4.36M 0.43%
+2,102
New +$4.15M
LPRO
53
Open Lending Corp
LPRO
$373M
$4.32M 0.43%
+123,491
New +$3.59M
QURE icon
54
uniQure
QURE
$2.68B
$4.31M 0.43%
+116,085
New +$4.9M
AOS icon
55
A.O. Smith
AOS
$8.38B
$4.25M 0.42%
+77,500
New +$4.27M
PAGS icon
56
PagSeguro Digital
PAGS
$2.57B
$4.18M 0.41%
73,471
+47,184
+179% +$2.12M
ALLY icon
57
Ally Financial
ALLY
$13.1B
$4.01M 0.4%
111,904
+17,976
+19% +$544K
ADV icon
58
Advantage Solutions
ADV
$484M
$3.95M 0.39%
12,000
CMAX
59
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$3.9M 0.39%
+8,333
New +$2.8M
VIEW
60
DELISTED
View, Inc. Class A Common Stock
VIEW
$3.79M 0.38%
+5,554
New +$3.44M
EPAM icon
61
EPAM Systems
EPAM
$4.69B
$3.75M 0.37%
+10,464
New +$3.49M
CLRB icon
62
Cellectar Biosciences
CLRB
$19.3M
$3.71M 0.37%
+5,750
New +$2.64M
XLB icon
63
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
$3.68M 0.36%
+101,678
New +$3.48M
CCCC icon
64
C4 Therapeutics
CCCC
$376M
$3.65M 0.36%
+101,692
New +$2.95M
CGRO
65
DELISTED
Collective Growth Corporation Class A Common Stock
CGRO
$3.57M 0.35%
+250,000
New +$2.72M
ACGL icon
66
Arch Capital
ACGL
$36.1B
$3.54M 0.35%
98,093
+51,514
+111% +$1.69M
CNH
67
CNH Industrial
CNH
$13.8B
$3.47M 0.34%
+315,975
New +$2.75M
OC icon
68
Owens Corning
OC
$11.5B
$3.46M 0.34%
+45,000
New +$3.28M
SNDX icon
69
Syndax Pharmaceuticals
SNDX
$1.84B
$3.43M 0.34%
+150,000
New +$3.11M
LYG icon
70
Lloyds Banking Group
LYG
$87.4B
$3.41M 0.34%
1,691,581
NTLA icon
71
Intellia Therapeutics
NTLA
$1.5B
$3.37M 0.33%
+59,568
New +$2.16M
CTLT
72
DELISTED
CATALENT, INC.
CTLT
$3.33M 0.33%
+32,000
New +$3.1M
WPX
73
DELISTED
WPX Energy, Inc.
WPX
$3.22M 0.32%
386,160
+333,660
+636% +$2.12M
ARVN icon
74
Arvinas
ARVN
$518M
$3.19M 0.32%
+37,600
New +$1.3M
META icon
75
Meta Platforms (Facebook)
META
$1.51T
$3.11M 0.31%
11,253
-4,213
-27% -$1.15M

Similar funds

Maven Securities's Q4 2020 Portfolio in Review

As of Q4 2020, Maven Securities held 972 positions worth $1.01B, down 17% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Maven Securities withdrew a net $355M in Q4 2020, closing 428 positions and reducing 71 holdings. Its most notable exit was Immunomedics Inc, an estimated $32.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Maven Securities opened a new position in Corelogic, Inc. worth $14.7M.

  • Maven Securities's largest Q4 2020 buy was Corelogic, Inc.: 189,483 shares worth $14.7M.
  • Maven Securities added most to AdaptHealth in Q4 2020, an estimated $14.9M increase.
  • Maven Securities's biggest Q4 2020 reduction was Triterras, Inc. Class A Ordinary Shares, cutting an estimated $15.2M.
  • Maven Securities fully exited Immunomedics Inc in Q4 2020, selling an estimated $32.8M.
  • Maven Securities's ten largest holdings make up 18% of its $1.01B portfolio in Q4 2020.
  • Maven Securities opened 385 new positions and closed 428 in Q4 2020.
  • Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.01B.

Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.